retatrutide phase 2 nejm 2023 obesity trial results from a new of (LY3437943; Eli Lilly) found that participants had considerable decreases in body weight at week 48, although this depended on the dose and varied due to Retatrutide Month 1 Results: What
USD22.08
USD42.08
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![동향리포트]GLP-1 수용체 작용제: 당뇨병 치료에서 체중 감량 치료제로의 진화 | Bio리포트 > 동향](https://www.ibric.org/_attach/bric/editor-image/2024/09/knmJPgFTBCMncfCXGnwQnkhyrX.png)
![후생신보] 당뇨병 치료에 있어서 비만 환자에게 GLP-1 유사체와 인슐린 병용의 임상적 효과 및 필요성](http://newsx.ecn.cdn.infralab.net/www.whosaeng.com/imgdata/whosaeng_com/201505/2015051147368917.jpg)
![학술특집] 최근 당뇨치료의 세계적 이슈, '인크레틴 제제'1 < 학술연구 < 학술·학회 < 기사본문](https://cdn.kmedinfo.co.kr/news/photo/201310/11203_2.jpg)
![약 이야기] 당뇨약이 비만약으로? 유행처럼 번지는 'GLP-1 유사체'](https://pds.joongang.co.kr/news/component/healthmedia/201809/14/133efb02e84ca.jpg)
![당뇨병 치료제] GLP1 receptor agonists(GLP-1 유사체) 알아보기](https://blog.kakaocdn.net/dna/crXsVy/btsGR1i9QNf/AAAAAAAAAAAAAAAAAAAAAB_JcsHgdS3PkGybTDkPOkVkXnoJknSwJnjF7mf8PSny/img.png?credential=yqXZFxpELC7KVnFOS48ylbz2pIh7yKj8&expires=1788188399&allow_ip=&allow_referer=&signature=2ek5jATtEWxAt1kDyYArECrbdZg%3D)
![후생신보] 대한당뇨병학회 및 심평원 초청 간담회<br>당뇨병 치료에 있어서 GLP-1 유사체의 임상적 효과 및 필요성](http://newsx.ecn.cdn.infralab.net/www.whosaeng.com/imgdata/whosaeng_com/201402/2014022723476078.jpg)
